State Of Tennessee, Treasury Department Affimed N.V. Transaction History

State Of Tennessee, Treasury Department

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$5.12 - $8.48 $233,328 - $386,450	-45,572 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$3.16 - $7.03 $206,370 - $459,108	-65,307 Reduced 58.9%	45,572 $265,000
Q3 2020 Nov 16, 2020	SELL	$3.26 - $4.73 $193,360 - $280,550	-59,313 Reduced 34.85%	110,879 $376,000
Q2 2020 Aug 13, 2020	SELL	$1.58 - $4.63 $75,546 - $221,378	-47,814 Reduced 21.93%	170,192 $785,000
Q4 2019 Feb 06, 2020	BUY	$2.25 - $3.07 $52,947 - $72,243	23,532 Added 12.1%	218,006 $597,000
Q2 2019 Aug 12, 2019	BUY	$2.6 - $4.21 $505,632 - $818,735	194,474 New	194,474 $558,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

Stay updated on State Of Tennessee, Treasury Department with notifications on news.